Civo BioScreening is looking for strategic partnerships to help it take forward its novel polymer screening technology.

Innate Pharma SA has applied for an initial public offering and listing on the Euronext in Paris, to raise funds to expand its pipeline of oncology therapeutics.

It may not be possible to write a rulebook on how to innovate, but there is no harm in reading attempts to do so.

Wine and biotechnology come together in yet another genome project.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

USA Today reports declining R&D budgets in the USA, albeit in, it seems, just one tech sector.

For a bunch of IT experts, the EU's IST World has come up with a baffling web site, especially when the idea is to make life easy for beginners.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.

The EU wants 25 per cent of transport energy will come from biofuels by the year 2030 – and is backing research that it will help it get there.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.